Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02254018
Brief Title: Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck

First Submitted : September 30, 2014
First Submitted that Met QC Criteria : September 30, 2014
First Posted : October 1, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 30, 2014
Last Update Posted : October 1, 2014 (Estimate)